EC Number   |
Natural Substrates |
|---|
   3.2.1.209 | alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-alpha-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc-2-pyridylamine + H2O |
- |
| 3.2.1.209 | alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-alpha-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc-N-Asn-[protein] + H2O |
- |
| 3.2.1.209 | alpha-D-mannopyranosyl-(1,2)-alpha-D-mannopyranosyl-(1,2)-alpha-D-mannopyranosyl-(1,3)-[alpha-D-mannopyranosyl-(1,2)-alpha-D-mannopyranosyl-(1,3)-[alpha-D-mannopyranosyl-(1,2)-alpha-D-mannopyranosyl-(1,6)]-alpha-D-mannopyranosyl-(1,6)]-beta-D-mannopyranosyl-(1,4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1,4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranose + H2O |
- |
| 3.2.1.209 | alpha1-antitrypsin null + H2O |
- |
| 3.2.1.209 | Glc3Man9GlcNAc2 + H2O |
from oligosaccharide-lipid |
| 3.2.1.209 | Man7GlcNAc2 + H2O |
from oligosaccharide-lipid, very low activity |
| 3.2.1.209 | Man9GlcNAc + H2O |
highly specific soluble catalytic domain of a larger membrane-bound form, does not act on synthetic substrates |
| 3.2.1.209 | Man9GlcNAc2 + H2O |
from thyroglobulin or oligosaccharide-lipid, trimming the substrate to Man8GlcNAc2, the substrate for oligosaccharide elongation |
| 3.2.1.209 | Manalpha(1-2)Manalpha(1-2)Manalpha(1-3)[Manalpha(1-2)Manalpha(1-6)[Manalpha(1-3)]Manalpha(1-6)]Manbeta(1-4)GlcNAcbeta(1-4)GlcNAc + H2O |
cytosolic isoform E-I |
| 3.2.1.209 | more |
generating the signal that targets misfolded glycoproteins for endoplasmic reticulum-associated protein degradation (ERAD) |
